KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gsk (GSK) Goodwill & Intangibles (2016 - 2026)

Gsk has reported Goodwill & Intangibles over the past 18 years, most recently at $9.8 billion for Q1 2026.

  • For Q1 2026, Goodwill & Intangibles rose 12.62% year-over-year to $9.8 billion; the TTM value through Mar 2026 reached $9.8 billion, up 12.62%, while the annual FY2025 figure was $31.6 billion, 9.48% up from the prior year.
  • Goodwill & Intangibles for Q1 2026 was $9.8 billion at Gsk, down from $31.6 billion in the prior quarter.
  • Over five years, Goodwill & Intangibles peaked at $32.6 billion in Q2 2022 and troughed at $8.3 billion in Q1 2023.
  • A 5-year average of $14.9 billion and a median of $9.0 billion in 2025 define the central range for Goodwill & Intangibles.
  • Biggest five-year swings in Goodwill & Intangibles: surged 123.3% in 2022 and later crashed 74.2% in 2023.
  • Year by year, Goodwill & Intangibles stood at $25.1 billion in 2022, then rose by 6.88% to $26.8 billion in 2023, then rose by 7.81% to $28.9 billion in 2024, then increased by 9.48% to $31.6 billion in 2025, then crashed by 68.92% to $9.8 billion in 2026.
  • Business Quant data shows Goodwill & Intangibles for GSK at $9.8 billion in Q1 2026, $31.6 billion in Q4 2025, and $9.6 billion in Q3 2025.